Optimization of Biosimilar Medications Collaborative Strategies - Mayo Clinic

This episode continues examining insights gained from the Optimization of Biosimilars Medications Collaborative.

 

Chelsee Jensen and Scott Soefje from Mayo Clinic discuss their participation in the project, key takeaways and what's on the horizon in the Biosimilar market. 

 

Speakers:

Chelsee J. Jensen, Pharm.D., BCPS, R.Ph.

Senior Pharmacy Specialist, Pharmaceutical Formulary Manager

Supply Chain Management

Mayo Clinic

 

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Director, Pharmacy Cancer Care

Assistant Professor of Pharmacy

Mayo Clinic

 

Moderator:

Jim Lichauer, PharmD, BCPS, FASHP

Sr PI Program Director, Pharmacy

Vizient

 

Show Notes:

[00:42] Current state of the Biosimilar market

[01:58] The financial opportunity available and what that opportunity might look like

[03:56] Key strategies and impactful strategies utilized during the collaborative

[07:07] Key takeaways from the collaborative project

[08:25] Moving Biosimilars into the retail space and what that might mean

[10:48] Navigating the complexities of medications covered under the pharmacy benefit

[11:46] Other Biosimilar products on the way

[12:30] Final thoughts and advice for organizations considering Biosimilars

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Google Podcasts

Android

Stitcher

RSS Feed